NKGen Biotech (NKGN) Institutional Ownership $0.16 +0.00 (+0.50%) As of 03:40 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NKGen Biotech (NYSE:NKGN)CurrentInstitutional OwnershipPercentage76.17%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$508.52KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$893.53K Get NKGN Insider Trade Alerts Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NKGN Institutional Buying and Selling by Quarter Remove Ads NKGen Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/25/2025 Polar Asset Management Partners Inc.500,000$328K0.0%-57.7%1.112% 2/17/2025 Polar Asset Management Partners Inc.500,000$328K0.0%-57.7%1.112% 2/13/2025 Advisory Research Inc.43,088$28K0.0%N/A0.096% 2/12/2025 Geode Capital Management LLC127,168$83K0.0%+12.8%0.283% 2/11/2025 Kepos Capital LP230,022$151K0.2%N/A0.512% 2/11/2025 Magnetar Financial LLC267,508$175K0.0%N/A0.595% 2/7/2025 Sequoia Financial Advisors LLC156,000$102K0.0%+126.1%0.347% 11/15/2024 Polar Asset Management Partners Inc.1,181,872$447K0.0%+9.4%3.342% 10/22/2024 Sequoia Financial Advisors LLC69,000$26K0.0%+273.0%0.268% 5/1/2024 Sequoia Financial Advisors LLC16,000$30K0.0%N/A0.070% 3/14/2024 University of Chicago550,000$1.51M2.1%N/A2.513% (Data available from 1/1/2016 forward)Remove Ads NKGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NKGN shares? During the previous two years, the following institutional investors and hedge funds held shares of NKGen Biotech shares: University of Chicago ($1.51M), Polar Asset Management Partners Inc. ($328K), Magnetar Financial LLC ($175K), Kepos Capital LP ($151K), Sequoia Financial Advisors LLC ($102K), and Geode Capital Management LLC ($83K), and Advisory Research Inc. ($28K).Learn more on NKGN's institutional investors. What percentage of NKGen Biotech stock is owned by institutional investors? 76.17% of NKGen Biotech stock is owned by institutional investors. Learn more on NKGN's institutional investor holdings. Which institutional investors have been buying NKGen Biotech stock? The following institutional investors have purchased NKGen Biotech stock in the last 24 months: University of Chicago ($550K), Magnetar Financial LLC ($267.51K), Kepos Capital LP ($230.02K), Sequoia Financial Advisors LLC ($153.50K), Polar Asset Management Partners Inc. ($101.87K), Advisory Research Inc. ($43.09K), and Geode Capital Management LLC ($14.45K). How much institutional buying is happening at NKGen Biotech? Institutional investors have bought a total of 1,360,444 shares in the last 24 months. This purchase volume represents approximately $2.02M in transactions. Which NKGen Biotech major shareholders have been selling company stock? The following institutional investors have sold NKGen Biotech stock in the last 24 months: Polar Asset Management Partners Inc. ($1.36M). How much institutional selling is happening at NKGen Biotech? Institutional investors have sold a total of 1,363,744 shares in the last 24 months. This volume of shares sold represents approximately $893.53K in transactions. Related Companies Q32 Bio Major Shareholders Rallybio Major Shareholders Lexaria Bioscience Major Shareholders Longeveron Major Shareholders Daré Bioscience Major Shareholders DURECT Major Shareholders Tenax Therapeutics Major Shareholders Enlivex Therapeutics Major Shareholders Cardio Diagnostics Major Shareholders Passage Bio Major Shareholders This page (NYSE:NKGN) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NKGN Stock Free NKGN Stock Alerts